Kristy Ainslie, Ph.D. applies her knowledge base in biomaterials, and immunology to develop new immune-modulatory therapies that treat and prevent infectious, and autoimmune diseases. Her lab aims to design practical and innovative formulations, taking into account the scalable production and applications in developing nations.
Technology/Technique Used: Polymer Synthesis
Animal Models, Bio-conjugate Chemistry, Drug Formulation, HPLC, Physicochemical Characterization, Polymer Synthesis, Blood-brain Barrier, Cancer, Drug Delivery, Nanomedicine, Nanoparticle, Neuroengineering, Opioids, Pediatrics, Structure Activity Relationship, Tumor Microenvironment
Confocal Microscopy, Drug Formulation, Fluorescence Microscopy, Polymer Synthesis, Primary Cell Culture Antibiotics, Bacterial resistance, Drug Delivery, Glioblastoma, Immunomodulation, Immunotherapy, Infectious Diseases, Nanoparticle, Peptide Delivery, Vaccines